Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04604613

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

Sponsor: M.D. Anderson Cancer Center

View on ClinicalTrials.gov

Summary

This study investigates whether molecular testing can help to predict the risk of endometrial cancer coming back (recurrence) after treatment in patients diagnosed with low risk endometrial cancer and scheduled to have surgery to remove the uterus and/or cervix (hysterectomy). Having sentinel lymph node mapping performed may help researchers to see if the cancer has spread in patients with low risk endometrial cancer.

Official title: Prediction of Recurrence Among Low Risk Endometrial Cancer Population

Key Details

Gender

FEMALE

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

518

Start Date

2012-11-08

Completion Date

2026-12-31

Last Updated

2026-03-09

Healthy Volunteers

No

Interventions

PROCEDURE

Bilateral Salpingectomy with Oophorectomy

Undergo standard of care bilateral salpingo-oophorectomy

PROCEDURE

Biospecimen Collection

Undergo collection of blood and tissue samples

PROCEDURE

Hysterectomy

Undergo standard of care hysterectomy

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Lymph Node Mapping

Undergo sentinel lymph node mapping

PROCEDURE

Sentinel Lymph Node Biopsy

Undergo sentinel lymph node biopsy

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States